PCORI To Solicit More Head-To-Head Comparative Studies
The Patient-Centered Outcomes Research Institute announces plans to encourage the submission of more proposals for head-to-head clinical comparative effectiveness studies. Among the research topics the institute will encourage are the Institute of Medicine’s top 100 priorities and recommendations from America’s Health Insurance Plans.
You may also be interested in...
There appeared to be support for the idea that if head-to-head studies are funded, they should focus on “high risk populations,” such as intravenous drug users.
Economists, mathematicians and behavioral scientists are among the non-health care specialists who could be essential to ensuring the wealth of comparative effectiveness research data available is used to its full potential, according to speakers at a recent CER event.
Research involving drugs has been limited since the Patient-Centered Outcomes Research Institute began project funding, but institute Executive Director Joe Selby expects that to change as PCORI prepares to issue funding announcements for pragmatic trials.